“Die weltweiten regulatorischen Rahmenbedingungen für CBD verändern sich sehr schnell. Unser Team hat nun eine Verpackung entwickelt, bei der sich die CBD-Produzenten darauf verlassen können, dass alle geltenden Bestimmungen erfüllt sind.
EMBELIA continues to evolve and acquires a leading logistics tool to create the necessary conditions for growth and development in a demanding market in terms of supply, quality and service. The Sucy-en-Brie storage site was moved this summer to Savigny-sur-Clairis.
Covering an area of 8000 m², the Savigny-sur-Clairis site has many advantages:
Use of the parenteral route of administration has risen sharply in recent years, with parenteral drugs now representing approximately 32% (by volume) of the global market [1]. Parenteral drug delivery, via injection or infusion, is essential for many biologics but is also commonly used for small molecules, low solubility drugs and delivery of nutritional and vitamin therapies.
Aufgrund einer Verordnung der Gemeinde Saint-Quentin-Lamotte vom 26.07.2019, ändert sich die Anschrift unseres Werkes vor Ort.
Bitte adressieren Sie etwaige Korrespondenz mit dem Werk, ab sofort, nur noch wie folgt:
VORHERIGE ADRESSE
SGD Pharma
Rue Eolis
PEA Bresle Maritime
80880 Saint-Quentin-Lamotte
At Suzhou Dialogue 2019 held by China Pharmaceutical Packaging Association (CNPPA) in Suzhou, SGD Pharma R&D Director Jingwei Zhang will present and deliver a speech at Forum of Technology and Regulation on September 2nd. His sharing will explore the performance and application of container made by tubular glass and molded glass.
